Orchid Pharma Limited has submitted a compliance certificate for the third quarter of the financial year 2025-26, which ended on December 31, 2025. The certificate was issued by M/s. Abhipra Capital Limited, the company's Registrar and Share Transfer Agent, confirming adherence to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended.

The company has requested that this intimation be taken on record by the stock exchanges. The announcement was made on January 8, 2026, and copies were sent to the National Securities Depository Limited and Central Depository Services (India) Limited.